Mesoblast | MSB - Ebit

Stock Price
2.47
Daily Change
-0.02 -0.80%
Monthly
-10.51%
Yearly
-18.21%
Q1 Forecast
2.48

Mesoblast reported $-42.11M in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Avita Medical AUD -8.66M 1.61M Jun/2025
Clinuvel Pharmaceuticals AUD 32.21M 14.41M Jun/2024
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
PYC Therapeutics AUD -25.84M 3M Dec/2024
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Starpharma Holdings AUD -1.03M 6.36M Dec/2023
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024